THE YENOS TEST
The Yenos test measures the level of microRNA cancer biomarkers known from the literature and from our studies to be overexpressed at the onset of a cancer. The Yenos test can be successfully conducted using either blood or urine of individuals 30 to 80 years old and delivers equally accurate results regardless of the sample type. The Yenos test is not recommended for pregnant women or people who were still exhibiting cancer symptoms in the last three years.
Testing for Cancer
$749
The Yenos test ($749) has been tested and shown to detect 6 cancers with higher sensitivity and specificity than any other test in development. No other test can claim multi-cancer detection with a urine sample.
The 6 cancer indications (prostate, pancreatic, lung, colorectal, breast and ovarian) account for over 53% of cancers in the US. No other test can claim the practically 100% sensitivity for newly diagnosed stage I/II.
In addition earlier medical studies with additional cancers suggest that the same test should detect those too.
The Yenos test does not identify the location of the cancer. A positive result serves as a warning sign and warrants a follow-up visit with your primary physician. A negative result indicates the absence of cancer.
The Yenos cancer test delivers the most value when used as a complementary check after standard screening guidelines have been followed. If you have completed the recommended screening suite but remain uncertain about the results, the Yenos test provides an independent second opinion to confirm or refute earlier findings.
A negative result indicates that the individual is cancer-free and in good overall health, which is a relief for health-conscious people who question their health every time they are tired, overworked, overstressed, or just "under the weather."